Zosano Pharma Corporation ZSANQ

Healthcare Biotechnology

Zosano Pharma Corp is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Zosano Pharma Corp is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Zosano Pharma Corp. Zosano Pharma Corp is a clinical-stage specialty pharmaceutical company. It has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of various indications. The company only operating segment being developing human pharmaceutical products. All the business activities of the firm is functioned through the market of the United States. Its product includes Qtrypta (M207) which is a formulation of zolmitriptan delivered utilizing an Adhesive Dermally-Applied Microarray technology.

EXPM:ZSANQ - Post by User

Zosano Pharma Corporation

<< Previous

Bullboard Posts

Next >>

Post by Humaniston Jul 02, 2019 3:01pm

85 Views

Post# 29880698

zsan presentation at AMecian heache society july 13th

Zosano Pharma Announces Upcoming Presentation at American Headache Society Annual Meeting

July 01, 2019 16:05 ET | Source: Zosano Pharma Corporation

FREMONT, Calif., July 01, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that a poster and e-poster describing Migraine-ACT scores, or measures of patient satisfaction with the management of their migraines, following Qtrypta™ therapy used over 6-12 months will be presented at the American Headache Society (AHS) 61^st Annual Scientific Meeting. The meeting will be held July 11-14, 2019 in Philadelphia.

Presentation Title:	Assessing the Long-Term Effectiveness of Qtrypta using the Migraine-ACT; Correlation with Electronic Diary Scores
Presenter:	Stewart J. Tepper, M.D., Dartmouth-Hitchcock Medical Center
Poster Number:	P230LB

e-Poster Presentation:
Date and Time:	July 13, 2019 1:00 p.m.
Location:	Room 6 in Hall A, Pennsylvania Convention Center